SCHEMBL29601119

SCHEMBL29601119

Cc1cccnc1C(=O)CBr

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.41
NPC1 O15118 3/20 0.41
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
GSK3B P49841 2/20 0.41
KDM4E B2RXH2 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
NPSR1 Q6W5P4 2/20 0.41
CYP1A2 P05177 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3701074 1.00 RAB9A (0.41) RAB9ANPC1CTNNB1WNT3AHTT
Bromide SCHEMBL1984185 0.98 RAB9A (0.41) RAB9ANPC1CTNNB1WNT3AHTT
SCHEMBL5314559 0.86 CTNNB1 (0.43) RAB9ANPC1CTNNB1WNT3AHTT
SCHEMBL5312789 0.83 BRD4 (0.43) RAB9ANPC1CTNNB1WNT3AHTT
SCHEMBL2479225 0.81 CTNNB1 (0.49) CTNNB1WNT3AKDM4EL3MBTL1NPSR1
Hydrochloric Acid SCHEMBL1981138 0.80 NOS3 (0.42) RAB9ANPC1CTNNB1WNT3AHTT
SCHEMBL22756416 0.80 CTNNB1 (0.44) CTNNB1WNT3AGSK3BKDM4EL3MBTL1
SCHEMBL2475007 0.80 BRD4 (0.41) RAB9ANPC1CTNNB1WNT3AHTT
SCHEMBL6110659 0.80 KDM4E (0.46) GSK3BKDM4EL3MBTL1NPSR1CYP1A2
SCHEMBL15988698 0.79 CTNNB1 (0.54) RAB9ANPC1CTNNB1WNT3AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed